公司概覽
業務類別 Diagnostics & Research
業務概覽 Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
公司地址 1261 Liberty Way, Vista, CA, USA, 92081
電話號碼 +1 760 560-1501
傳真號碼 --
公司網頁 https://www.exagen.com
員工數量 209
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. John Aballi Director, President and Chief Executive Officer 美元 525.00K 30/04/2025
Mr. Jeffrey G. Black Chief Financial Officer; Principal Accounting Officer and Corporate Secretary 美元 141.54K 30/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. John Aballi Director, President and Chief Executive Officer 30/04/2025
Dr. Tina S. Nova, PhD Executive Chairman of the Board 30/04/2025
Mr. Charles S. McKhann Independent Director 17/07/2025
Mr. Bruce C. Robertson, PhD Independent Director 30/04/2025
Ms. Ana Hooker Independent Director 30/04/2025
Mr. Frank Stokes Independent Director 30/04/2025
Dr. Scott D. Kahn,PhD Independent Director 30/04/2025
Mr. Paul Kim Independent Director 30/04/2025
 
所屬ETF (更新日期: 07/03/2026 03:43)
代號 名稱 佔比% 持有日期
IWCiShares Micro-Cap ETF0.18%28/02/2026
DFASDimensional US Small Cap ETF0.11%27/02/2026
ROSCHartford Multifactor Small Cap ETF0.06%28/02/2026
DFACDimensional US Core Equity 2 ETF0.02%27/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.02%27/02/2026
DCORDimensional US Core Equity 1 ETF0.01%27/02/2026
GUGGuggenheim Active Allocation Fund0.0003%30/11/2025
DWASInvesco Dorsey Wright SmallCap Momt ETF<0.000001%02/01/2026
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%27/02/2026
QQQSInvesco NASDAQ Future Gen 200 ETF<0.000001%22/12/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.